Czechia – Pharmaceutical products – Medicinal product containing the active substance FARICIMAB
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The subject of the performance of the public contract is the continuous supply of a medicinal product containing the active substance faricimab (ATC S01LA09) for the treatment of patients in approved indications according to the SPC valid on the date of submission of tenders, to the extent according to the needs of the contracting authority. The aim of the contracting authority is to ensure for its activity continuous supplies of medicinal products for the treatment of patients for a period of 1 year from the entry into force of the framework purchase agreement.